Andreas Wilmen

1.5k total citations
12 papers, 1.2k citations indexed

About

Andreas Wilmen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andreas Wilmen has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andreas Wilmen's work include Diabetes Treatment and Management (3 papers), Neuropeptides and Animal Physiology (3 papers) and Cell death mechanisms and regulation (2 papers). Andreas Wilmen is often cited by papers focused on Diabetes Treatment and Management (3 papers), Neuropeptides and Animal Physiology (3 papers) and Cell death mechanisms and regulation (2 papers). Andreas Wilmen collaborates with scholars based in Germany and United States. Andreas Wilmen's co-authors include Rüdiger Göke, Elisabeth Perzborn, Susanne Roehrig, Jens Pohlmann, Andreas Straub, Youhai Chen, Brendan Hilliard, Alexandra Göke, Yi‐Guang Chen and Kaimei Song and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Andreas Wilmen

12 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Wilmen Germany 9 505 384 330 305 198 12 1.2k
Swaminathan Murugappan United States 15 336 0.7× 351 0.9× 129 0.4× 75 0.2× 458 2.3× 27 1.3k
Jeanny Ohan France 6 414 0.8× 163 0.4× 416 1.3× 49 0.2× 179 0.9× 10 1.0k
Lia Guidotti Italy 16 378 0.7× 204 0.5× 189 0.6× 68 0.2× 240 1.2× 27 964
Jan Willem N. Akkerman Netherlands 18 254 0.5× 280 0.7× 95 0.3× 35 0.1× 520 2.6× 29 1.2k
P. Salbach Germany 9 211 0.4× 195 0.5× 180 0.5× 37 0.1× 109 0.6× 15 811
Amanda J. Unsworth United Kingdom 17 264 0.5× 175 0.5× 111 0.3× 43 0.1× 347 1.8× 43 884
Dalila Marques United States 17 359 0.7× 107 0.3× 54 0.2× 78 0.3× 135 0.7× 27 905
Conxita de Castellarnau Spain 16 155 0.3× 170 0.4× 165 0.5× 33 0.1× 118 0.6× 29 679
Shufang Gu United States 12 247 0.5× 90 0.2× 281 0.9× 23 0.1× 114 0.6× 13 807
Tatjana Albrektsen Denmark 12 528 1.0× 43 0.1× 84 0.3× 53 0.2× 222 1.1× 14 913

Countries citing papers authored by Andreas Wilmen

Since Specialization
Citations

This map shows the geographic impact of Andreas Wilmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wilmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wilmen more than expected).

Fields of papers citing papers by Andreas Wilmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Wilmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wilmen. The network helps show where Andreas Wilmen may publish in the future.

Co-authorship network of co-authors of Andreas Wilmen

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Wilmen. A scholar is included among the top collaborators of Andreas Wilmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Wilmen. Andreas Wilmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schaefer, Martina, et al.. (2019). Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI. Journal of Molecular Biology. 431(24). 4817–4833. 43 indexed citations
2.
Wilmen, Andreas, et al.. (2009). The genomic organization of the human GLP-1 receptor gene. Experimental and Clinical Endocrinology & Diabetes. 106(4). 299–302. 2 indexed citations
3.
Perzborn, Elisabeth, et al.. (2005). In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor. Journal of Thrombosis and Haemostasis. 3(3). 514–521. 469 indexed citations
4.
Göke, Alexandra, Rüdiger Göke, Heidi Trusheim, et al.. (2002). DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochemical and Biophysical Research Communications. 297(1). 78–82. 79 indexed citations
5.
Hilliard, Brendan, et al.. (2001). Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 166(2). 1314–1319. 166 indexed citations
6.
Song, Kaimei, Yi‐Guang Chen, Rüdiger Göke, et al.. (2000). Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression. The Journal of Experimental Medicine. 191(7). 1095–1104. 302 indexed citations
7.
Wilmen, Andreas, Brigitte Van Eyll, Burkhard Göke, & Rüdiger Göke. (1997). Five Out of Six Tryptophan Residues in the N -Terminal Extracellular Domain of the Rat GLP-1 Receptor Are Essential for its Ability to Bind GLP-1. Peptides. 18(2). 301–305. 42 indexed citations
8.
Wilmen, Andreas & Johannes H. Hegemann. (1996). The chromatin of the Saccharomyces cerevisiae centromere shows cell-type specific changes. Chromosoma. 104(7). 489–503. 3 indexed citations
9.
Wilmen, Andreas & Johannes H. Hegemann. (1996). The chromatin of theSaccharomyces cerevisiae centromere shows cell-type specific changes. Chromosoma. 104(7). 489–503. 4 indexed citations
10.
Wilmen, Andreas, B Göke, & Rüdiger Göke. (1996). The isolated N‐terminal extracellular domain of the glucagon‐like peptide‐1 (GLP)‐1 receptor has intrinsic binding activity. FEBS Letters. 398(1). 43–47. 43 indexed citations
11.
Eyll, Brigitte Van, Burkhard Göke, Andreas Wilmen, & Rüdiger Göke. (1996). Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function. Peptides. 17(4). 565–570. 23 indexed citations
12.
Wilmen, Andreas, Horst Pick, Rainer Niedenthal, Mark Sen-Gupta, & Johannes H. Hegemann. (1994). The yeast centromere CDEI/Cpf1 complex: differences betweenin vitrobinding andin vivofunction. Nucleic Acids Research. 22(14). 2791–2800. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swaminathan Murugappan Breakdown of academic impact, for papers by Jeanny Ohan Breakdown of academic impact, for papers by Lia Guidotti Breakdown of academic impact, for papers by Jan Willem N. Akkerman Breakdown of academic impact, for papers by P. Salbach Breakdown of academic impact, for papers by Amanda J. Unsworth Breakdown of academic impact, for papers by Dalila Marques Breakdown of academic impact, for papers by Conxita de Castellarnau Breakdown of academic impact, for papers by Shufang Gu Breakdown of academic impact, for papers by Tatjana Albrektsen
Rankless by CCL
2026